SAN DIEGO--(BUSINESS WIRE)--DJO Incorporated, (NYSE:DJO), a global provider of products and services that promote musculoskeletal and vascular health, announced the completion of its Agreement and Plan of Merger, dated as of July 15, 2007, with ReAble Therapeutics, Inc., effective today, November 20, 2007. Pursuant to the terms of the merger agreement, holders of DJO’s common stock will receive $50.25 in cash for each share of DJO common stock that they owned immediately prior to the effective time of the merger. As a result of the merger, DJO’s common stock will cease to trade on the New York Stock Exchange at the close of the market today and will be delisted. The transaction is valued at approximately $1.5 billion.
